PCRX logo

Pacira BioSciences (PCRX) Net Income

Annual Net Income

$41.95 M
+$26.05 M+163.72%

December 31, 2023

Summary

Performance

1-Year Change

+163.72%

3-Year Change

-71.17%

5-Year Change

+9007.64%

15-Year Change

+198.46%

PCRX Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

88.59%
PCRX annual net profit is higher than 88.59% of companies in Healthcare sector

High & Low

All-time High

$145.52 M
PCRX annual net profit is currently -71.17% below its historical high of $145.52 million

3-Year Low

$15.91 M
PCRX annual net profit is currently +163.72% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
PCRX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
PCRX next annual earnings announcement is scheduled for Feb 28, 2025

OtherPCRXprofitabilitymetrics:

Annual Net Margin

6.22%
PCRX annual net profit margin is 6.22%

Annual Revenue

$674.98 M
PCRX annual revenue is $674.98 million

Annual Gross Profit

$490.31 M
PCRX annual gross profit is $490.31 million

Annual EPS

$0.89
PCRX annual earnings per share is $0.89

Quarterly Net Income

-$143.47 M
-$162.35 M-859.64%

September 30, 2024

Summary

Performance

3-Month Change

-859.64%

1-Year Change

-1421.29%

3-Year Change

-2201.14%

5-Year Change

-2201.14%

PCRX Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

1.61%
PCRX quarterly net profit is higher than 1.61% of companies in Healthcare sector

High & Low

All-time High

$130.12 M
PCRX quarterly net profit is currently -210.26% below its historical high of $130.12 million

3-Year Low

-$143.47 M
PCRX quarterly net profit is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PCRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
PCRX next earnings announcement is scheduled for Feb 28, 2025

OtherPCRXprofitabilitymetrics:

Quarterly Net Margin

-85.11%
PCRX quarterly net profit margin is -85.11%

Quarterly Revenue

$168.57 M
PCRX quarterly revenue is $168.57 million

Quarterly Gross Profit

$129.71 M
PCRX quarterly gross profit is $129.71 million

Quarterly EPS

-$3.11
PCRX quarterly earnings per share is -$3.11

TTM Net Income

-$90.73 M
-$154.32 M-242.67%

September 30, 2024

Summary

Performance

3-Month Change

-242.67%

1-Year Change

-1399.31%

3-Year Change

-336.04%

5-Year Change

-336.04%

PCRX TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

23.54%
PCRX TTM net profit is higher than 23.54% of companies in Healthcare sector

High & Low

All-time High

$174.08 M
PCRX TTM net profit is currently -152.12% below its historical high of $174.08 million

3-Year Low

-$90.73 M
PCRX TTM net profit is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PCRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
PCRX next earnings announcement is scheduled for Feb 28, 2025

OtherPCRXprofitabilitymetrics:

Annual Net Margin

6.22%
PCRX annual net profit margin is 6.22%

TTM Revenue

$694.96 M
PCRX TTM revenue is $694.96 million

TTM Gross Profit

$516.72 M
PCRX TTM gross profit is $516.72 million

TTM EPS

-$2.01
PCRX TTM earnings per share is -$2.01

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

$41.95 M
PCRX annual net profit is $41.95 million

Annual Revenue

$674.98 M
PCRX annual revenue is $674.98 million

Annual Cost Of Goods Sold

$184.67 M
PCRX annual cost of goods sold is $184.67 million

Annual Operating Expenses

$402.99 M
PCRX annual total operating expenses is $402.99 million

Annual Interest Expense

$17.31 M
PCRX annual interest expense is $17.31 million

Annual Income Tax

$19.75 M
PCRX annual income tax is $19.75 million

PCRX Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+163.7%-1421.3%-1399.3%
3 y3 years-71.2%-2201.1%-336.0%
5 y5 years+9007.6%-2201.1%-336.0%

PCRX Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-0.1%+163.7%-656.9%at low-228.8%at low
5 y5-year-71.2%+480.9%-210.3%at low-152.1%at low
alltimeall time-71.2%+165.7%-210.3%at low-152.1%at low

Pacira BioSciences Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$143.47 M(-859.6%)
-$90.73 M(-242.7%)
Jun 2024
-
$18.89 M(+110.3%)
$63.59 M(-9.8%)
Mar 2024
-
$8.98 M(-63.9%)
$70.47 M(+68.0%)
Dec 2023
$41.95 M(+163.7%)
$24.87 M(+129.0%)
$41.95 M(+500.8%)
Sep 2023
-
$10.86 M(-57.9%)
$6.98 M(-252.9%)
Jun 2023
-
$25.76 M(-231.9%)
-$4.57 M(-56.3%)
Mar 2023
-
-$19.54 M(+93.4%)
-$10.46 M(-165.7%)
Dec 2022
$15.91 M(-62.1%)
-$10.10 M(+1357.7%)
$15.91 M(-23.8%)
Sep 2022
-
-$693.00 K(-103.5%)
$20.88 M(-46.8%)
Jun 2022
-
$19.88 M(+191.1%)
$39.23 M(+2.1%)
Mar 2022
-
$6.83 M(-233.1%)
$38.44 M(-8.4%)
Dec 2021
$41.98 M(-71.2%)
-$5.13 M(-129.0%)
$41.98 M(-31.9%)
Sep 2021
-
$17.66 M(-7.4%)
$61.63 M(-64.6%)
Jun 2021
-
$19.08 M(+84.0%)
$174.08 M(+17.8%)
Mar 2021
-
$10.37 M(-28.6%)
$147.73 M(+1.5%)
Dec 2020
$145.52 M(-1421.0%)
$14.52 M(-88.8%)
$145.52 M(+15.4%)
Sep 2020
-
$130.12 M(-1890.1%)
$126.12 M(-1350.6%)
Jun 2020
-
-$7.27 M(-189.1%)
-$10.09 M(>+9900.0%)
Mar 2020
-
$8.16 M(-266.9%)
-$86.00 K(-99.2%)
Dec 2019
-$11.02 M(+2238.9%)
-$4.89 M(-19.7%)
-$11.02 M(-610.7%)
Sep 2019
-
-$6.09 M(-323.0%)
$2.16 M(-71.6%)
Jun 2019
-
$2.73 M(-198.5%)
$7.60 M(+2.2%)
Mar 2019
-
-$2.77 M(-133.4%)
$7.44 M(-1679.2%)
Dec 2018
-$471.00 K(-98.9%)
$8.29 M(-1394.5%)
-$471.00 K(-88.7%)
Sep 2018
-
-$640.00 K(-125.0%)
-$4.16 M(-62.6%)
Jun 2018
-
$2.56 M(-124.0%)
-$11.12 M(-66.7%)
Mar 2018
-
-$10.68 M(-332.4%)
-$33.42 M(-21.6%)
Dec 2017
-$42.61 M(+12.3%)
$4.59 M(-160.5%)
-$42.61 M(-16.7%)
Sep 2017
-
-$7.60 M(-61.5%)
-$51.18 M(-22.2%)
Jun 2017
-
-$19.74 M(-0.6%)
-$65.75 M(+21.8%)
Mar 2017
-
-$19.87 M(+400.2%)
-$53.96 M(+42.2%)
DateAnnualQuarterlyTTM
Dec 2016
-$37.95 M(-2144.7%)
-$3.97 M(-82.1%)
-$37.95 M(+4.0%)
Sep 2016
-
-$22.16 M(+178.5%)
-$36.47 M(+225.0%)
Jun 2016
-
-$7.96 M(+106.5%)
-$11.22 M(+244.5%)
Mar 2016
-
-$3.85 M(+54.3%)
-$3.26 M(-275.5%)
Dec 2015
$1.86 M(-113.5%)
-$2.50 M(-180.9%)
$1.86 M(-81.7%)
Sep 2015
-
$3.09 M(>+9900.0%)
$10.16 M(+149.8%)
Jun 2015
-
$8000.00(-99.4%)
$4.07 M(-515.3%)
Mar 2015
-
$1.26 M(-78.3%)
-$979.00 K(-92.9%)
Dec 2014
-$13.72 M(-78.5%)
$5.80 M(-293.1%)
-$13.72 M(-56.4%)
Sep 2014
-
-$3.00 M(-40.4%)
-$31.47 M(-27.2%)
Jun 2014
-
-$5.04 M(-56.1%)
-$43.25 M(-17.2%)
Mar 2014
-
-$11.48 M(-4.0%)
-$52.25 M(-18.2%)
Dec 2013
-$63.91 M(+22.2%)
-$11.96 M(-19.1%)
-$63.91 M(-6.4%)
Sep 2013
-
-$14.78 M(+5.4%)
-$68.30 M(-1.4%)
Jun 2013
-
-$14.03 M(-39.4%)
-$69.26 M(+9.0%)
Mar 2013
-
-$23.14 M(+41.6%)
-$63.52 M(+21.5%)
Dec 2012
-$52.28 M(+20.7%)
-$16.35 M(+3.8%)
-$52.28 M(+2.1%)
Sep 2012
-
-$15.74 M(+89.8%)
-$51.22 M(+13.9%)
Jun 2012
-
-$8.30 M(-30.3%)
-$44.98 M(-1.0%)
Mar 2012
-
-$11.89 M(-22.2%)
-$45.45 M(+4.9%)
Dec 2011
-$43.33 M(+59.6%)
-$15.28 M(+60.7%)
-$43.33 M(+23.5%)
Sep 2011
-
-$9.51 M(+8.5%)
-$35.09 M(+4.8%)
Jun 2011
-
-$8.76 M(-10.4%)
-$33.48 M(+6.2%)
Mar 2011
-
-$9.78 M(+38.8%)
-$31.53 M(+16.1%)
Dec 2010
-$27.15 M(-14.4%)
-$7.04 M(-10.8%)
-$27.15 M(-6.6%)
Sep 2010
-
-$7.90 M(+16.0%)
-$29.08 M(+4.7%)
Jun 2010
-
-$6.81 M(+26.4%)
-$27.77 M(+32.5%)
Mar 2010
-
-$5.39 M(-39.9%)
-$20.95 M(+34.6%)
Dec 2009
-$31.71 M(-24.3%)
-$8.97 M(+36.1%)
-$15.56 M(+136.1%)
Sep 2009
-
-$6.59 M
-$6.59 M
Dec 2008
-$41.86 M
-
-

FAQ

  • What is Pacira BioSciences annual net profit?
  • What is the all time high annual net income for Pacira BioSciences?
  • What is Pacira BioSciences annual net income year-on-year change?
  • What is Pacira BioSciences quarterly net profit?
  • What is the all time high quarterly net income for Pacira BioSciences?
  • What is Pacira BioSciences quarterly net income year-on-year change?
  • What is Pacira BioSciences TTM net profit?
  • What is the all time high TTM net income for Pacira BioSciences?
  • What is Pacira BioSciences TTM net income year-on-year change?

What is Pacira BioSciences annual net profit?

The current annual net income of PCRX is $41.95 M

What is the all time high annual net income for Pacira BioSciences?

Pacira BioSciences all-time high annual net profit is $145.52 M

What is Pacira BioSciences annual net income year-on-year change?

Over the past year, PCRX annual net profit has changed by +$26.05 M (+163.72%)

What is Pacira BioSciences quarterly net profit?

The current quarterly net income of PCRX is -$143.47 M

What is the all time high quarterly net income for Pacira BioSciences?

Pacira BioSciences all-time high quarterly net profit is $130.12 M

What is Pacira BioSciences quarterly net income year-on-year change?

Over the past year, PCRX quarterly net profit has changed by -$154.32 M (-1421.29%)

What is Pacira BioSciences TTM net profit?

The current TTM net income of PCRX is -$90.73 M

What is the all time high TTM net income for Pacira BioSciences?

Pacira BioSciences all-time high TTM net profit is $174.08 M

What is Pacira BioSciences TTM net income year-on-year change?

Over the past year, PCRX TTM net profit has changed by -$97.71 M (-1399.31%)